Table 2.

Cell and progenitor counts after mobilization in L-selectin-deficient mice

Blood CFU-Cs (per mL)BM CFU-Cs (×103/femur)Spleen CFU-Cs (×103/spleen)WBC (per μL)BMNC (×106/femur)Platelets (×103/μL)
WT PBS 19 ± 6 72.5 ± 3.8 9.8 ± 0.8 2 700 ± 441 17.4 ± 0.9 853 ± 49 
WT fucoidin 271 ± 61* 65.4 ± 2.5 10.7 ± 1.8 22 510 ± 3 141* 14.8 ± 0.7* 435 ± 45* 
L−/− PBS 19 ± 12 62.1 ± 5.1 8.4 ± 0.9 3 460 ± 533 16.2 ± 0.6 837 ± 44 
L−/− fucoidin 269 ± 63* 70.8 ± 4.9 11.4 ± 1.3 19 033 ± 1 777* 13.7 ± 0.5* 448 ± 46* 
Blood CFU-Cs (per mL)BM CFU-Cs (×103/femur)Spleen CFU-Cs (×103/spleen)WBC (per μL)BMNC (×106/femur)Platelets (×103/μL)
WT PBS 19 ± 6 72.5 ± 3.8 9.8 ± 0.8 2 700 ± 441 17.4 ± 0.9 853 ± 49 
WT fucoidin 271 ± 61* 65.4 ± 2.5 10.7 ± 1.8 22 510 ± 3 141* 14.8 ± 0.7* 435 ± 45* 
L−/− PBS 19 ± 12 62.1 ± 5.1 8.4 ± 0.9 3 460 ± 533 16.2 ± 0.6 837 ± 44 
L−/− fucoidin 269 ± 63* 70.8 ± 4.9 11.4 ± 1.3 19 033 ± 1 777* 13.7 ± 0.5* 448 ± 46* 

Wild-type (WT) and L-selectin-deficient (L−/−) mice were treated with 2 sequential doses of fucoidan (25 mg/kg). Six hours after the initial dose, blood, bone marrow (BM), and spleen were harvested. Blood nucleated cell (white blood cell [WBC]), platelets, and bone marrow nucleated cell (BMNC) counts were determined using an automated cell counter. An aliquot of cells was plated in methylcellulose media and read 8 days after cultivation to assess progenitor counts.

*

P < .05; n = 9-10 mice, except spleen where n = 7.

CFU-Cs, colony-forming units in culture.

or Create an Account

Close Modal
Close Modal